BNF 84 : September 2022 - March 2023

BNF 84 : September 2022 - March 2023 - London : BMJ Group, 2022 - xvii, 1844p

The BNF is designed as a digest for rapid reference and it may not always include all the information necessary for prescribing and dispensing. Also, less detail is given on areas such as obstetrics, malignant disease, and anaesthesia since it is expected that those undertaking treatment will have specialist knowledge and access to specialist literature. BNF for Children should be consulted for detailed information on the use of medicines in children. The BNF should be interpreted in the light of professional knowledge and supplemented as necessary by specialised publications and by reference to the product literature. Information is also available from Medicines Information Services.

Please refer to digital versions of BNF for the most up-to-date content. BNF is published in print but interim updates are issued and published in the digital versions of BNF. The publishers work to ensure that the information is as accurate and up-to-date as possible at the date of publication, but knowledge and best practice in this field change regularly. BNF's accuracy and currency cannot be guaranteed and neither the publishers nor the authors accept any responsibility for errors or omissions. While considerable efforts have been made to check the material in this publication, it should be treated as a guide only. Prescribers, pharmacists and other healthcare professionals are advised to check https://www.bnf.org/ for information about key updates and corrections. The British National Formulary (BNF) is the first choice for concise medicines information. Trusted by healthcare professionals across the world to support confident decision-making at the point of care. The new edition (BNF 84) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines.

9780857114310


Pharmacopoeias
Pharmacology
Prescriptions, drug

QV 738
London Health Libraries Koha Consortium privacy notice